A novel approach to analysing DNA for signs of mutation and disease is leading to highly accurate tests for early-stage cancer, antibiotic resistance and genetic disorders, potentially revolutionising diagnostic medicine and saving lives.
New rare disease research goals for the next decade
The International Rare Diseases Research Consortium is proud to announce the new vision and goals for 2017-2027. The new vision will enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention. The European Commission is committed to support IRDiRC's new targets through Horizon 2020, the current EU framework programme for research and innovation.
Commission launches public consultation on Health and Care in the Digital Single Market
The European Commission launches a public consultation today on how Europe should promote digital innovation in health and care, for the benefits of citizens and of health systems in Europe. This consultation will help us to identify how to empower citizens, medical professionals and researchers; to ensure a right for citizens to have an electronic health record that they can access from everywhere in the EU, to improve prevention, rapid response to pandemic threats, personalised treatments and care.
- Press release
- Public Consultation: Transformation Health and Care in the Digital Single Market
- Digital Single Market - consultations
Innovative Medicines Initiative – new calls out
The Innovative Medicines Initiative has launched two Calls for proposals open, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. The deadline for both calls is 24 October 2017, 17:00, Brussels time.
Antimicrobial Resistance: Commission steps us the fight with new Action Plan
The Commission continues to scale up its fight against antimicrobial resistance (AMR), with the launch of a second European Action Plan.
The new Action Plan is based on a One Health approach and focusses on supporting Member States, particularly in establishing, implementing and monitoring their National Action Plans. It also brings together EU funds and instruments to promote innovation and research against AMR and strengthen the EU's leading role in global fora, notably within the international organisations and with major trade partners.
The EU delegation met the Lithuanian delegation at BIO International Convention
The Lithuanian Minister of Economy, H.E. Mindaugas Sinkevičius, visits the EU pavilion at BIO International Convention. Talks around smart specialization, research infrastructures and the Lithuania’s dramatic rise in the European Innovation Scoreboard were on the agenda.
Fast track to orphan drugs enjoys a full house at BIO 2017
With over 110 participants, the session organised by DG Research and Innovation presented opportunities for public funding and regulatory support for orphan drug development available in Europe and the US with testimonies from companies benefiting from such support and stakeholder collaboration. Representatives of the European Commission, the International Rare Diseases Research Consortium, the US Food and Drug Administration and the European Medicines Agency engaged in a very constructive debate and took questions from the audience.
- European Medicines Agency
- International Rare Diseases Research Consortium
- US Food and Drug Administration
Launch of the African Access Initiative
The Initiative along with a white paper on cancer burden and emerging crisis in Africa, was launched at BIO 2017 in San Diego. Through the European and Developing Countries Clinical Trials Partnership (EDCTP), the European Commission has been actively involved in sub-Saharan Africa. EDCTP's objective in that area is to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases.
- New African Access Initiative
- European and Developing Countries Clinical Trials Partnership
- BIO International Convention
20-24 August 2017, Paris, France - ISN-ESN Biennial Meeting
28-29 August 2017, London, United Kingdom - 2nd International Congress on Contemporary Issues in Women Cancers and Gynecologic Oncology